Detalles de la búsqueda
1.
SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab.
Front Neurol
; 14: 1114667, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36873431
2.
Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose phase I studies with healthy volunteers.
Antimicrob Agents Chemother
; 56(9): 4729-37, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22733065
3.
A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome.
J Neurodev Disord
; 14(1): 10, 2022 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123401
4.
Bioavailability and pharmacokinetic profile of balovaptan, a selective, brain-penetrant vasopressin 1a receptor antagonist, in healthy volunteers.
Expert Opin Investig Drugs
; 30(8): 893-901, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34176392
5.
Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man.
Sci Rep
; 11(1): 7700, 2021 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33833333
6.
Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients.
Br J Clin Pharmacol
; 70(6): 834-43, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21175439
Resultados
1 -
6
de 6
1
Próxima >
>>